Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2006; 48:1416-1424, doi:10.1016/j.jacc.2006.06.045 (Published online 11 September 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2006.06.045v1
48/7/1416    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dalal, D.
Right arrow Articles by Judge, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dalal, D.
Right arrow Articles by Judge, D. P.

CLINICAL RESEARCH

Penetrance of Mutations in Plakophilin-2 Among Families With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

Darshan Dalal, MD, MPH*, Cynthia James, ScM, PhD*, Rajiv Devanagondi, BA*, Crystal Tichnell, MGC*, April Tucker, MGC*, Kalpana Prakasa, MD*, Philip J. Spevak, MD, FACC{dagger}, David A. Bluemke, MD, PhD*,{ddagger}, Theodore Abraham, MD, FACC*, Stuart D. Russell, MD, FACC*, Hugh Calkins, MD, FACC* and Daniel P. Judge, MD*,*

* Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
{dagger} Division of Cardiology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland
{ddagger} Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, Maryland

Manuscript received March 20, 2006; revised manuscript received May 9, 2006, accepted June 6, 2006.

* Reprint requests and correspondence: Dr. Daniel Judge, Johns Hopkins University School of Medicine, 720 Rutland Avenue, Ross 1049, Baltimore, Maryland 21205. (Email: djudge{at}jhmi.edu).

OBJECTIVES: The purpose of our study was to characterize the penetrance of PKP2 mutations among family members of people with arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) and to examine clinical features and predictors of disease among PKP2 mutation carriers.

BACKGROUND: Arrhythmogenic right ventricular dysplasia/cardiomyopathy is an inherited cardiomyopathy characterized by fatty-fibrous myocardial replacement of the right ventricle, ventricular arrhythmias, and right ventricular dysfunction. Mutations in PKP2, the gene encoding plakophilin-2, are found in 11% to 43% of ARVD/C probands.

METHODS: The study population was composed of 64 individuals in 9 families with an ARVD/C proband previously shown to carry a pathogenic PKP2 mutation. The diagnosis of ARVD/C was established based on task force criteria (TFC) set by the European Society of Cardiology.

RESULTS: In addition to the probands, PKP2 mutations were present in 52% of relatives screened. Forty-nine percent of PKP2 mutation carriers met TFC. Among mutation carriers who did not meet full TFC, 50% met at least some TFC criteria besides family history. Pedigrees showed wide intra-familial variability, ranging from severe disease with early death to individuals who were completely asymptomatic late in life. Male PKP2 mutation carriers were more likely to have structural and conduction abnormalities as determined by imaging studies, signal-averaged electrocardiography, and 24-h ambulatory electrocardiography (p < 0.05).

CONCLUSIONS: PKP2 mutations in a group of North American families with ARVD/C have both reduced penetrance and variable expressivity. Gender may have an influence on penetrance of PKP2 mutations, with male mutation carriers more likely to develop specific phenotypic manifestations of this disease.

Abbreviations and Acronyms
  ARVD/C = arrhythmogenic right ventricular dysplasia/cardiomyopathy
  DNA = deoxyribonucleic acid
  ECG = electrocardiogram
  ICD = implantable cardioverter-defibrillator
  RV = right ventricle/ventricular
  SAECG = signal-averaged electrocardiogram
  TFC = task force criteria (for diagnosis of ARVD/C)
  VT = ventricular tachycardia




This article has been cited by other articles:


Home page
EuropaceHome page
M. J. Ackerman, S. G. Priori, S. Willems, C. Berul, R. Brugada, H. Calkins, A. J. Camm, P. T. Ellinor, M. Gollob, R. Hamilton, et al.
HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)
Europace, August 1, 2011; 13(8): 1077 - 1109.
[Full Text] [PDF]


Home page
CirculationHome page
D. P. Judge
Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: A Family Affair
Circulation, June 14, 2011; 123(23): 2661 - 2663.
[Full Text] [PDF]


Home page
CirculationHome page
M. G. P. J. Cox, P. A. van der Zwaag, C. van der Werf, J. J. van der Smagt, M. Noorman, Z. A. Bhuiyan, A. C. P. Wiesfeld, P. G. A. Volders, I. M. van Langen, D. E. Atsma, et al.
Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Pathogenic Desmosome Mutations in Index-Patients Predict Outcome of Family Screening: Dutch Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Genotype-Phenotype Follow-Up Study
Circulation, June 14, 2011; 123(23): 2690 - 2700.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S. I. Sarvari, K. H. Haugaa, O.-G. Anfinsen, T. P. Leren, O. A. Smiseth, E. Kongsgaard, J. P. Amlie, and T. Edvardsen
Right ventricular mechanical dispersion is related to malignant arrhythmias: a study of patients with arrhythmogenic right ventricular cardiomyopathy and subclinical right ventricular dysfunction
Eur. Heart J., May 1, 2011; 32(9): 1089 - 1096.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P. Charron, M. Arad, E. Arbustini, C. Basso, Z. Bilinska, P. Elliott, T. Helio, A. Keren, W. J. McKenna, L. Monserrat, et al.
Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
Eur. Heart J., November 2, 2010; 31(22): 2715 - 2726.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc ImagingHome page
S. V. Raman, C. Basso, H. Tandri, and M. R. G. Taylor
Imaging Phenotype vs Genotype in Nonhypertrophic Heritable Cardiomyopathies: Dilated Cardiomyopathy and Arrhythmogenic Right Ventricular Cardiomyopathy
Circ Cardiovasc Imaging, November 1, 2010; 3(6): 753 - 765.
[Full Text] [PDF]


Home page
Circ. Res.Home page
M. Delmar and W. J. McKenna
The Cardiac Desmosome and Arrhythmogenic Cardiomyopathies: From Gene to Disease
Circ. Res., September 17, 2010; 107(6): 700 - 714.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc GenetHome page
S. Sen-Chowdhry, P. Syrris, A. Pantazis, G. Quarta, W. J. McKenna, and J. C. Chambers
Mutational Heterogeneity, Modifier Genes, and Environmental Influences Contribute to Phenotypic Diversity of Arrhythmogenic Cardiomyopathy
Circ Cardiovasc Genet, August 1, 2010; 3(4): 323 - 330.
[Abstract] [Full Text] [PDF]


Home page
Circ Arrhythm ElectrophysiolHome page
M. G. P. J. Cox, J. J. van der Smagt, M. Noorman, A. C. Wiesfeld, P. G. A. Volders, I. M. van Langen, D. E. Atsma, D. Dooijes, A. C. Houweling, P. Loh, et al.
Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Diagnostic Task Force Criteria: Impact of New Task Force Criteria
Circ Arrhythm Electrophysiol, April 1, 2010; 3(2): 126 - 133.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Xu, Z. Yang, M. Vatta, A. Rampazzo, G. Beffagna, K. Pillichou, S. E. Scherer, J. Saffitz, J. Kravitz, W. Zareba, et al.
Compound and Digenic Heterozygosity Contributes to Arrhythmogenic Right Ventricular Cardiomyopathy
J. Am. Coll. Cardiol., February 9, 2010; 55(6): 587 - 597.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc GenetHome page
A. D. den Haan, B. Y. Tan, M. N. Zikusoka, L. I. Llado, R. Jain, A. Daly, C. Tichnell, C. James, N. Amat-Alarcon, T. Abraham, et al.
Comprehensive Desmosome Mutation Analysis in North Americans With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
Circ Cardiovasc Genet, October 1, 2009; 2(5): 428 - 435.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. Dalal, H. Tandri, D. P. Judge, N. Amat, R. Macedo, R. Jain, C. Tichnell, A. Daly, C. James, S. D. Russell, et al.
Morphologic Variants of Familial Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: A Genetics-Magnetic Resonance Imaging Correlation Study
J. Am. Coll. Cardiol., April 14, 2009; 53(15): 1289 - 1299.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Qian, B. Mohapatra, T. Akasaka, J. Liu, K. Ocorr, J. A. Towbin, and R. Bodmer
Transcription factor neuromancer/TBX20 is required for cardiac function in Drosophila with implications for human heart disease
PNAS, December 16, 2008; 105(50): 19833 - 19838.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Sen-Chowdhry, P. Syrris, and W. J. McKenna
Role of Genetic Analysis in the Management of Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
J. Am. Coll. Cardiol., November 6, 2007; 50(19): 1813 - 1821.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. P. Judge, N. M. Johnson, A. L. Cirino, and C. Y. Ho
Heart Failure and Genomics
J. Am. Coll. Cardiol., March 13, 2007; 49(10): 1106 - 1106.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement